-
Entity Type
-
Individual
-
Role
-
COO, and President, Athenex Pharmaceutical Division.
-
Issuer Symbol
-
ATNX
There are no Buy or Sell transactions made by JEFFREY YORDON since 07 Jan 2025
Holdings reported by JEFFREY YORDON for Athenex, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
245,943 |
$55,337 |
$0.2250 |
03 Aug 2022 |
Direct |
|
|
| Stock Option (Right to Buy) |
150,000 |
|
|
03 Aug 2022 |
Direct |
Common Stock |
150,000 |
| Restricted Stock Units |
37,500 |
|
|
03 Aug 2022 |
Direct |
Common Stock |
50,000 |
Transactions reported by JEFFREY YORDON for Athenex, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.